Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yuanlei Fu

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Frontiers in Pharmacology|January 10, 2022
RNA Drug Delivery Using Biogenic Nanovehicles for Cancer TherapyNuannuan Li, Yiying Sun, Yuanlei Fu, et al.
Pharmaceutics|June 26, 2026
Orally Administered Self-Microemulsifying Celastrol Alleviates Rheumatoid Arthritis by Modulating the Expression of TNF-αBoqin Ma, Yan Li, Jiahui Zhang, et al.
Drug Delivery|June 28, 2021
Prodrug-based nano-delivery strategy to improve the antitumor ability of carboplatin <i>in vivo</i> and <i>in vitro</i>Tingting Lang, Nuannuan Li, Jing Zhang, et al.
Pathogens (Basel, Switzerland)|August 29, 2024
Advances in Engineering Circular RNA VaccinesZhongyan Zhang, Yuanlei Fu, Xiaoli Ju, et al.
Molecular Pharmaceutics|April 17, 2024
Recent Progress of Small Interfering RNA Delivery on the Market and Clinical StageFan Guo, Yan Li, Wenjun Yu, et al.
Medcomm|February 12, 2024
Drug development advances in human genetics-based targetsXiaoxia Zhang, Wenjun Yu, Yan Li, et al.
Drug Delivery and Translational Research|March 8, 2024
Oxaliplatin lipidated prodrug synergistically enhances the anti-colorectal cancer effect of IL12 mRNAHui Liu, Yating Du, Desheng Zhan, et al.
Advanced Materials (Deerfield Beach, Fla.)|August 1, 2018
Binary Cooperative Prodrug Nanoparticles Improve Immunotherapy by Synergistically Modulating Immune Tumor MicroenvironmentBing Feng, Fangyuan Zhou, Bo Hou, et al.
Pharmaceutical Development and Technology|May 22, 2026
Strategies for inhibiting the burst release effect in peptide long-acting release delivery systemsXianhua Zhang, Yuanlei Fu, Yuan Tan, et al.
Drug Delivery|February 6, 2023
Novel Pt(IV) prodrug self-assembled nanoparticles with enhanced blood circulation stability and improved antitumor capacity of oxaliplatin for cancer therapyYuanlei Fu, Ying Kong, Xiangping Li, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Frontiers in Pharmacology|January 10, 2022
RNA Drug Delivery Using Biogenic Nanovehicles for Cancer TherapyNuannuan Li, Yiying Sun, Yuanlei Fu, et al.
Pharmaceutics|June 26, 2026
Orally Administered Self-Microemulsifying Celastrol Alleviates Rheumatoid Arthritis by Modulating the Expression of TNF-αBoqin Ma, Yan Li, Jiahui Zhang, et al.
Drug Delivery|June 28, 2021
Prodrug-based nano-delivery strategy to improve the antitumor ability of carboplatin <i>in vivo</i> and <i>in vitro</i>Tingting Lang, Nuannuan Li, Jing Zhang, et al.
Pathogens (Basel, Switzerland)|August 29, 2024
Advances in Engineering Circular RNA VaccinesZhongyan Zhang, Yuanlei Fu, Xiaoli Ju, et al.
Molecular Pharmaceutics|April 17, 2024
Recent Progress of Small Interfering RNA Delivery on the Market and Clinical StageFan Guo, Yan Li, Wenjun Yu, et al.
Medcomm|February 12, 2024
Drug development advances in human genetics-based targetsXiaoxia Zhang, Wenjun Yu, Yan Li, et al.
Drug Delivery and Translational Research|March 8, 2024
Oxaliplatin lipidated prodrug synergistically enhances the anti-colorectal cancer effect of IL12 mRNAHui Liu, Yating Du, Desheng Zhan, et al.
Advanced Materials (Deerfield Beach, Fla.)|August 1, 2018
Binary Cooperative Prodrug Nanoparticles Improve Immunotherapy by Synergistically Modulating Immune Tumor MicroenvironmentBing Feng, Fangyuan Zhou, Bo Hou, et al.
Pharmaceutical Development and Technology|May 22, 2026
Strategies for inhibiting the burst release effect in peptide long-acting release delivery systemsXianhua Zhang, Yuanlei Fu, Yuan Tan, et al.
Drug Delivery|February 6, 2023
Novel Pt(IV) prodrug self-assembled nanoparticles with enhanced blood circulation stability and improved antitumor capacity of oxaliplatin for cancer therapyYuanlei Fu, Ying Kong, Xiangping Li, et al.
Pageof 2